Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

By K. Uesaka, N. Boku, A. Fukutomi, Y. Okamura, M. Konishi, I. Matsumoto, Y. Kaneoka, Y. Shimizu, S. Nakamori, H. Sakamoto and 10 more. The Lancet, 2016

959 citations recorded by the source corpus.

Subfields: Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/6befd131bcb9979c48fef54517cb2447c2570554